| Axon ID |
Name |
Description |
From price |
|
1408
|
PD0325901
|
MEK1 and MEK2 inhibitor |
€50.00 |
|
1683
|
Y 27632 dihydrochloride
|
ROCK1 and ROCK2 inhibitor |
€65.00 |
|
2128
|
Stem Cell 2i inhibitor Set
|
Set of MEK inhibitor PD0325901 (Axon 1408) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€90.00 |
|
2129
|
Stem Cell 3i inhibitor Set
|
Set of FGFR inhibitor SU5402 (Axon 1667), MEK inhibitor PD184352 (Axon 1368) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€130.00 |
|
5004
|
Stem Cell LSB inhibitor Set
|
Set of BMP inhibitor LDN 193189 (Axon 1509) and TGF-β inhibitor SB 431542 (Axon 1661) |
€90.00 |
|
5005
|
Stem Cell LSC inhibitor Set
|
Set of LDN 193189 HCl, SB 431542 and CHIR99021, inhibitors of BMP, TGF-β, and GSK-3 resp. |
€130.00 |
|
5006
|
Stem Cell CSD inhibitor Set
|
Set of CHIR99021, SU5402, and DAPT, inhibitors of GSK-3, FGFR, and γ-secretase, resp. |
€140.00 |
|
5007
|
Stem Cell 5i inhibitor Set
|
Set of five inhibitors for neural differentiation of human pluripotent stem cells. |
€200.00 |
|
5008
|
Stem Cell RG-BIX inhibitor Set
|
Set of RG 108 and BIX 01294 HCl, inhibitors of DNMT and HMTase, respectively |
€60.00 |
|
5009
|
Stem Cell 4i inhibitor Set
|
Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.) |
€170.00 |
|
2381
|
WH-4-023
|
Orally active src-family selective lck inhibitor |
€90.00 |
|
2511
|
IM 12
|
GSK-3β inhibitor attenuating neuronal differentiation of human NPCs |
€95.00 |
|
2504
|
SB 590885
|
Selective inhibitor of B-Raf kinase with application in stem cell therapy |
€95.00 |
|
5010
|
Naive Stem Cell NHSM inhibitor Set
|
Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs |
€230.00 |
|
2753
|
CCG 232601
|
Rho/MRTF/SRF transcriptional pathway inhibitor |
€160.00 |
|
2780
|
KD025
|
Selective ATP-competitive inhibitor of ROCK2 |
€95.00 |
|
2778
|
Squarunkin A
|
Selective UNC119–cargo interaction inhibitor |
€125.00 |
|
2817
|
RAF709
|
Potent, selective, and efficacious B-Raf and C-Raf protein kinase inhibitor |
€120.00 |
|
3067
|
Belvarafenib
|
Orally bioavailable pan-Raf protein kinase inhibitor |
€115.00 |
|
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€210.00 |
|
3154
|
rac-BRD0705
|
GSK3α inhibitor |
€140.00 |
|
2931
|
BRD0705
|
First-in-class, paralog selective GSK3α inhibitor |
€210.00 |
|
3092
|
CCG-203971
|
Rho/MRTF/SRF transcriptional pathway inhibitor |
€60.00 |
|
3284
|
Saracatinib
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
3346
|
BIX02188
|
Potent MEK5 inhibitor |
€110.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
3556
|
LXH254
|
Potent, selective and orally available type II B/C RAF inhibitor |
€180.00 |
|
3579
|
Tideglusib
|
GSK-3 inhibitor |
€60.00 |
|
3697
|
Binimetinib
|
Potent, selective, non-ATP-competitive and orally available allosteric inhibitor of MEK1/2 |
€60.00 |
|
3848
|
Fasudil hydrochloride
|
Orally active ROCK inhibitor; Ca2+ channel antagonist |
€50.00 |
|
3874
|
RDEA119
|
Potent and highly selective small molecule allosteric MEK inhibitor |
Inquire |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
4033
|
TAK-632
|
Potent and selective pan-RAF inhibitor |
Inquire |
|
3936
|
Bisindolylmaleimide I
|
Potent and selective PKC inhibitor |
€120.00 |
|
4148
|
GDC-0973
|
Orally bioavailable, potent and selective small-molecule inhibitor of mitogen-activated protein kinase 1 |
Recently added
|
Inquire |